1. Home
  2. NBIX vs TRU Comparison

NBIX vs TRU Comparison

Compare NBIX & TRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$166.05

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Logo TransUnion

TRU

TransUnion

SELL

Current Price

$82.13

Market Cap

14.2B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
NBIX
TRU
Founded
1992
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
15.5B
14.2B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
NBIX
TRU
Price
$166.05
$82.13
Analyst Decision
Strong Buy
Buy
Analyst Count
29
22
Target Price
★ $207.50
$90.19
AVG Volume (30 Days)
1.3M
★ 3.2M
Earning Date
11-02-2026
10-27-2026
Dividend Yield
N/A
★ 0.69%
EPS Growth
41.95
★ 60.00
EPS
★ 5.26
3.59
Revenue
$161,626,000.00
★ $4,576,300,000.00
Revenue This Year
$36.46
$12.67
Revenue Next Year
$17.43
$5.94
P/E Ratio
$31.49
★ $21.75
Revenue Growth
★ 977.51
9.38
52 Week Low
$122.14
$60.96
52 Week High
$186.12
$89.12

Technical Indicators

Market Signals
Indicator
NBIX
TRU
Relative Strength Index (RSI) 76.47 58.28
Support Level $152.67 $72.28
Resistance Level $169.57 $81.46
Average True Range (ATR) 3.61 3.78
MACD 2.23 0.50
Stochastic Oscillator 86.44 67.55

Price Performance

Historical Comparison
NBIX
TRU

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About TRU TransUnion

TransUnion, along with Equifax and Experian, is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services. TransUnion operates in over 30 countries. About 20%-25% of its revenue comes from international markets.

Share on Social Networks: